TrialJournal of gastroenterology2017

The combination of elbasvir and grazoprevir for the treatment of chronic HCV infection in Japanese patients: a randomized phase II/III study.

Hiromitsu Kumada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.